Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64% Market Closed
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

P/S
Price to Sales

8.2
Current
8.9
Median
7.6
Industry
Lower than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
8.2
=
Market Cap
11.1B SEK
/
Revenue
1.4B SEK
All Countries
Close
Revenue Growth P/S to Growth
SE
Biogaia AB
STO:BIOG B
Average P/S: 3 466 979.5
8.2
41%
0.2
FR
Pharnext SCA
OTC:PNEXF
38 134 846.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
34%
0.3
US
E
Epizyme Inc
F:EPE
1 847.4
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.3
220%
0.1

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
7.9
2-Years Forward
P/S
6.9
3-Years Forward
P/S
6.1

See Also

Discover More